Hence, special attention should be given to an evaluationof tear fluid composition for the development of a preclinical diagnosis of PD.So far, only data on the increase in the TNF-α level in the tear fluid ofPD patients are available [39]. This evidence concerns the gene TNF and Parkinson disease.